Rights and permissions
About this article
Cite this article
Atorvastatin best value for money for secondary CHD prevention. Pharmacoecon. Outcomes News 408, 5 (2003). https://doi.org/10.1007/BF03276117
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03276117